ClinicalTrialsFinder

Ureteral Cancer Clinical Trials in Tianjin, Outside U.S.

1 recruitingTianjin, Outside U.S., China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer

Neoadjuvant TherapyTislelizumabPD-1 Inhibitor+3 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07125547